233 related articles for article (PubMed ID: 32724349)
1. Blood cell parameters as prognostic predictors of disease development for patients with advanced non-small cell lung cancer.
Wang L; Si H; Wang J; Feng L; Zhai W; Dong S; Yu Z
Oncol Lett; 2020 Aug; 20(2):1101-1110. PubMed ID: 32724349
[TBL] [Abstract][Full Text] [Related]
2. Elevated pretreatment neutrophil/white blood cell ratio and monocyte/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: Results from a large cohort.
Yuan C; Li N; Mao X; Liu Z; Ou W; Wang SY
Thorac Cancer; 2017 Jul; 8(4):350-358. PubMed ID: 28544400
[TBL] [Abstract][Full Text] [Related]
3. Low lymphocyte-to-white blood cell ratio and high monocyte-to-white blood cell ratio predict poor prognosis in gastric cancer.
Feng F; Sun L; Zheng G; Liu S; Liu Z; Xu G; Guo M; Lian X; Fan D; Zhang H
Oncotarget; 2017 Jan; 8(3):5281-5291. PubMed ID: 28029656
[TBL] [Abstract][Full Text] [Related]
4. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
5. Decreased monocyte-to-lymphocyte ratio was associated with satisfied outcomes of first-line PD-1 inhibitors plus chemotherapy in stage IIIB-IV non-small cell lung cancer.
Zheng L; Xiong A; Wang S; Xu J; Shen Y; Zhong R; Lu J; Chu T; Zhang W; Li Y; Zheng X; Han B; Zhong H; Nie W; Zhang X
Front Immunol; 2023; 14():1094378. PubMed ID: 36776882
[TBL] [Abstract][Full Text] [Related]
6. Preoperative monocyte-to-lymphocyte ratio predicts recurrence in gastrointestinal stromal tumors.
Cananzi FCM; Minerva EM; Samà L; Ruspi L; Sicoli F; Conti L; Fumagalli Romario U; Quagliuolo VL
J Surg Oncol; 2019 Jan; 119(1):12-20. PubMed ID: 30426498
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
Wang J; Liu Y; Mi X; Shao M; Liu L
Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
[TBL] [Abstract][Full Text] [Related]
8. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
9. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
Solmaz Medeni S; Acar C; Olgun A; Acar A; Seyhanlı A; Taskıran E; Sevindik OG; Alacacıoglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH
Clin Transplant; 2018 Sep; 32(9):e13359. PubMed ID: 30053318
[TBL] [Abstract][Full Text] [Related]
10. Combination of PLR, MLR, MWR, and Tumor Size Could Significantly Increase the Prognostic Value for Gastrointestinal Stromal Tumors.
Feng F; Tian Y; Liu S; Zheng G; Liu Z; Xu G; Guo M; Lian X; Fan D; Zhang H
Medicine (Baltimore); 2016 Apr; 95(14):e3248. PubMed ID: 27057867
[TBL] [Abstract][Full Text] [Related]
11. The Ratio of Preoperative Serum Biomarkers Predicts Prognosis in Patients With Oral Squamous Cell Carcinoma.
Ding M; Song Y; Jing J; Tian M; Ding L; Li Q; Zhou C; Dong H; Ni Y; Mou Y
Front Oncol; 2021; 11():719513. PubMed ID: 34552873
[TBL] [Abstract][Full Text] [Related]
12. Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients.
Wu G; Yao Y; Bai C; Zeng J; Shi D; Gu X; Shi X; Song Y
Thorac Cancer; 2015 May; 6(3):275-87. PubMed ID: 26273373
[TBL] [Abstract][Full Text] [Related]
13. Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort.
Jalali A; Miresse D; Fahey MR; Ni Mhaonaigh N; McGuire A; Bourke E; Kerin MJ; Brown JAL
Curr Oncol; 2022 Oct; 29(10):7512-7523. PubMed ID: 36290868
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
15. The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small cell lung cancer patients treated with EGFR TKI.
Phan TT; Ho TT; Nguyen HT; Nguyen HT; Tran TB; Nguyen ST
Int J Gen Med; 2018; 11():423-430. PubMed ID: 30510441
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer.
Li YX; Chang JY; He MY; Wang HR; Luo DQ; Li FH; Li JH; Ran L
J Oncol; 2021; 2021():2939162. PubMed ID: 34539781
[TBL] [Abstract][Full Text] [Related]
17. Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab.
Sánchez-Gastaldo A; Muñoz-Fuentes MA; Molina-Pinelo S; Alonso-García M; Boyero L; Bernabé-Caro R
Transl Lung Cancer Res; 2021 Jun; 10(6):2509-2522. PubMed ID: 34295658
[TBL] [Abstract][Full Text] [Related]
18. Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
Solmaz S; Uzun O; Acar C; Sevindik OG; Piskin O; Ozsan HG; Demirkan F; Undar B; Alacacioglu A; Ozcan MA; Alacacioglu I
J Lab Physicians; 2018; 10(4):363-369. PubMed ID: 30498304
[TBL] [Abstract][Full Text] [Related]
19. A High Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Advanced Gallbladder Cancer Receiving Chemotherapy.
Choi YH; Lee JW; Lee SH; Choi JH; Kang J; Lee BS; Paik WH; Ryu JK; Kim YT
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1045-1051. PubMed ID: 30842131
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment.
Da L; Qu Z; Zhang C; Shen Y; Huang W; Zhang Y; Gu K
Front Oncol; 2023; 13():1144875. PubMed ID: 37035159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]